Bevacizumab plus capecitabine and oxaliplatin (XELOX) as first-line treatment for elderly patients with metastatic colorectal cancer (mCRC) suitable for combination chemotherapy: Efficacy and safety findings from the phase II BECOX study (GEMCAD Study Gro

Jorge Fernández, Monica

Statistics

Statistics

View Usage Statistics

Identifiers

Identifiers

URI: http://hdl.handle.net/20.500.11940/2282

ISSN: 0959-8049

Full record

Services

Services

RIS

Mendeley

Linksolver

Date issued

2013

Journal title

EUROPEAN JOURNAL OF CANCER

Type of content

Artigo